For research use only. Not for therapeutic Use.
Mitiglinide calcium(Cat No.:I007995)is a medication used to manage type 2 diabetes mellitus. It is an oral hypoglycemic agent belonging to the class of meglitinides, which work by stimulating the pancreas to release insulin in response to meals. Mitiglinide helps control blood sugar levels by increasing insulin secretion in a glucose-dependent manner, reducing the risk of hypoglycemia. It is typically taken shortly before meals to prevent postprandial hyperglycemia. While effective, it is often prescribed in combination with other diabetes medications as part of a broader treatment plan to optimize blood glucose control.
Catalog Number | I007995 |
CAS Number | 145525-41-3 (calcium) |
Synonyms | KAD-1229; KAD 1229; KAD1229; S 21403; Mitiglinide calcium; Glufast.;calcium 2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoate |
Molecular Formula | C38H48CaN2O6 |
Purity | ≥95% |
Target | Potassium Channel |
Solubility | Soluble in DMSO |
Storage | 0 - 4 °C for short term, or -20 °C for long term |
IUPAC Name | calcium;(2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate |
InChI | InChI=1S/2C19H25NO3.Ca/c2*21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14;/h2*1-3,6-7,15-17H,4-5,8-13H2,(H,22,23);/q;;+2/p-2/t2*15-,16+,17-;/m00./s1 |
InChIKey | PMRVFZXOCRHXFE-FMEJWYFOSA-L |
SMILES | C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)[O-].C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)[O-].[Ca+2] |